This article is part of a Special Issue “SBN 2014”. Women are more vulnerable to stress-and
fear-based disorders, such as anxiety and post-traumatic stress disorder. Despite the …

Males and females sometimes significantly differ in their propensity to develop neurological
disorders. Females suffer more from mood disorders such as depression and anxiety …

Objective Little is known about the risk of anxiety in women during midlife and the
menopausal transition. We examined anxiety as a cluster of four symptoms and determined …

Aim Depression is common and may have significant implications for the individual, their
families and work and for the health care system. The menopause transition (MT) may be an …

Background Anxiety disorders are the second leading mental health-related cause of
disability-adjusted life-years (DALYs) and years lived with disability (YLDs) worldwide. This …

Women are more likely to develop an anxiety disorder than men. Yet, preclinical models of
anxiety were largely developed in male rodents, with poorly understood predictive validity …

Rationale Resveratrol (RSV) has been indicated to exhibit beneficial effects on depression
and anxiety treatment by suppression of inflammatory processes. Depression triggered by …

Objective Menopausal transition and early postmenopausal years have been described as a
“window of vulnerability” for the development of depressive symptoms or depression (new or …

The menopausal transition is often accompanied by psycho-vegetative symptoms, including
stress and anxiety symptoms. Identifying stress and anxiety and intervening early can have …

Many women experience vasomotor, psychosocial, physical and sexual symptoms during
their menopausal life-stage. Specifically, the psychosocial symptoms of menopause can …